Bliss GVS Pharma Limited (BLISSGVS.NS)
INR 119.02
(2.24%)
INR 119.02
(2.24%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.23 Billion INR | 25.94% |
| 2022 | 986.49 Million INR | -2.63% |
| 2021 | 1.01 Billion INR | 13.27% |
| 2020 | 894.47 Million INR | -19.52% |
| 2019 | 1.11 Billion INR | -26.43% |
| 2018 | 1.51 Billion INR | 41.87% |
| 2017 | 1.06 Billion INR | -44.42% |
| 2016 | 1.91 Billion INR | 10.56% |
| 2015 | 1.73 Billion INR | 55.53% |
| 2014 | 1.11 Billion INR | 77.5% |
| 2013 | 627.64 Million INR | -39.98% |
| 2012 | 1.04 Billion INR | 25.32% |
| 2011 | 834.49 Million INR | 51.37% |
| 2010 | 551.28 Million INR | 15.33% |
| 2009 | 477.99 Million INR | 12.43% |
| 2008 | 425.15 Million INR | 16.11% |
| 2007 | 366.15 Million INR | 460.72% |
| 2006 | 65.3 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 274.81 Million INR | 27.82% |
| 2024 Q2 | 344.95 Million INR | 25.52% |
| 2023 Q3 | 421.62 Million INR | -30.4% |
| 2023 Q1 | 180.24 Million INR | 315.89% |
| 2023 FY | 1.24 Billion INR | 25.94% |
| 2023 Q4 | 215.01 Million INR | -49.0% |
| 2023 Q2 | 605.78 Million INR | 236.09% |
| 2022 Q2 | 220.95 Million INR | -35.58% |
| 2022 Q4 | 43.34 Million INR | -91.1% |
| 2022 FY | 986.49 Million INR | -2.63% |
| 2022 Q1 | 343.01 Million INR | 111.71% |
| 2022 Q3 | 486.93 Million INR | 120.37% |
| 2021 Q4 | 162.02 Million INR | -45.51% |
| 2021 Q1 | 302.67 Million INR | 113.19% |
| 2021 FY | 1.01 Billion INR | 13.27% |
| 2021 Q2 | 251.11 Million INR | -17.03% |
| 2021 Q3 | 297.34 Million INR | 18.41% |
| 2020 Q2 | 276.92 Million INR | 82.3% |
| 2020 Q1 | 151.9 Million INR | -2.14% |
| 2020 FY | 894.47 Million INR | -19.52% |
| 2020 Q4 | 141.97 Million INR | -58.14% |
| 2020 Q3 | 339.16 Million INR | 22.48% |
| 2019 Q4 | 155.22 Million INR | -48.21% |
| 2019 Q1 | 461.87 Million INR | 13.03% |
| 2019 Q2 | 219.68 Million INR | -52.44% |
| 2019 Q3 | 299.71 Million INR | 36.43% |
| 2019 FY | 1.11 Billion INR | -26.43% |
| 2018 FY | 1.51 Billion INR | 41.87% |
| 2018 Q3 | 413.45 Million INR | 5.5% |
| 2018 Q4 | 408.62 Million INR | -1.17% |
| 2018 Q2 | 391.88 Million INR | 1.97% |
| 2018 Q1 | 384.29 Million INR | 0.6% |
| 2017 Q4 | 382.01 Million INR | -12.85% |
| 2017 FY | 1.06 Billion INR | -44.42% |
| 2017 Q2 | 577.54 Million INR | -7.59% |
| 2017 Q1 | 624.98 Million INR | -13.48% |
| 2017 Q3 | 438.37 Million INR | -24.1% |
| 2016 Q1 | 444.8 Million INR | -11.85% |
| 2016 FY | 1.91 Billion INR | 10.56% |
| 2016 Q4 | 722.33 Million INR | 67.34% |
| 2016 Q3 | 431.66 Million INR | 10.05% |
| 2016 Q2 | 392.23 Million INR | -11.82% |
| 2015 Q2 | 453.91 Million INR | 18.3% |
| 2015 FY | 1.73 Billion INR | 55.53% |
| 2015 Q4 | 504.6 Million INR | 54.84% |
| 2015 Q3 | 325.87 Million INR | -28.21% |
| 2015 Q1 | 383.7 Million INR | 0.0% |
| 2014 FY | 1.11 Billion INR | 77.5% |
| 2013 FY | 627.64 Million INR | -39.98% |
| 2012 Q4 | 175.69 Million INR | -33.46% |
| 2012 FY | 1.04 Billion INR | 25.32% |
| 2012 Q1 | 247.4 Million INR | 0.0% |
| 2012 Q2 | 366.34 Million INR | 48.07% |
| 2012 Q3 | 264.03 Million INR | -27.93% |
| 2011 FY | 834.49 Million INR | 51.37% |
| 2010 FY | 551.28 Million INR | 15.33% |
| 2009 FY | 477.99 Million INR | 12.43% |
| 2008 FY | 425.15 Million INR | 16.11% |
| 2007 FY | 366.15 Million INR | 460.72% |
| 2006 FY | 65.3 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 78.621% |
| Hester Biosciences Limited | 364.77 Million INR | -237.473% |
| Aarti Drugs Limited | 7.14 Billion INR | 82.78% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | 60.647% |
| Albert David Limited | 1.33 Billion INR | 7.753% |
| Alembic Limited | 767.77 Million INR | -60.335% |
| Alkem Laboratories Limited | 19.46 Billion INR | 93.675% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -417.965% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -5859.532% |
| Brooks Laboratories Limited | -72.25 Million INR | 1803.76% |
| Eris Lifesciences Limited | 5.18 Billion INR | 76.243% |
| FDC Limited | 3.03 Billion INR | 59.423% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 86.291% |
| Gufic Biosciences Limited | 2.89 Billion INR | 57.461% |
| Hikal Limited | 1.49 Billion INR | 17.615% |
| Ind-Swift Limited | 1.22 Billion INR | -0.411% |
| Innova Captab Limited | 2.53 Billion INR | 51.409% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | 75.092% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -475.127% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 76.277% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | 35.426% |
| Lupin Limited | 27.75 Billion INR | 95.565% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -4383.214% |
| Medico Remedies Limited | 277.11 Million INR | -344.215% |
| Morepen Laboratories Limited | 4.17 Billion INR | 70.507% |
| Nectar Lifesciences Limited | 3.89 Billion INR | 68.36% |
| Orchid Pharma Limited | 2.36 Billion INR | 47.863% |
| Procter & Gamble Health Limited | 2.78 Billion INR | 55.815% |
| RPG Life Sciences Limited | 2.29 Billion INR | 46.298% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -491.685% |
| Sigachi Industries Limited | 1.47 Billion INR | 16.48% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 131.95% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | 73.283% |
| Themis Medicare Limited | 1.3 Billion INR | 5.533% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Vaishali Pharma Limited | 6.29 Million INR | -19458.325% |
| Wanbury Limited | 1.7 Billion INR | 27.894% |
| Windlas Biotech Limited | 1.29 Billion INR | 5.227% |
| ZIM Laboratories Limited | 1.09 Billion INR | -12.101% |
| Ind-Swift Laboratories Limited | 2 Billion INR | 38.727% |
| Ipca Laboratories Limited | 29.59 Billion INR | 95.841% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 98.82% |
| Venus Remedies Limited | 534.65 Million INR | -130.244% |
| Sakar Healthcare Limited | 495.5 Million INR | -148.433% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 98.822% |
| Divi's Laboratories Limited | 18.31 Billion INR | 93.277% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | 72.485% |
| Mankind Pharma Limited | 40.86 Billion INR | 96.988% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Laurus Labs Limited | 3.94 Billion INR | 68.824% |
| Neuland Laboratories Limited | 5.31 Billion INR | 76.853% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 83.677% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 81.068% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 97.288% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -98.22% |
| Wockhardt Limited | 140 Million INR | -779.286% |
| Bal Pharma Limited | 214.56 Million INR | -473.709% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 98.182% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -123.174% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | 82.963% |
| Shilpa Medicare Limited | 3.76 Billion INR | 67.274% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 19.67 Billion INR | 93.744% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -43385.576% |
| Granules India Limited | 6.52 Billion INR | 81.144% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -393.88% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 95.141% |
| NATCO Pharma Limited | 25.96 Billion INR | 95.258% |
| Suven Life Sciences Limited | -1.22 Billion INR | 200.422% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | 76.444% |
| Indoco Remedies Limited | 1.52 Billion INR | 19.247% |
| Alpa Laboratories Limited | 61.51 Million INR | -1901.14% |
| Lasa Supergenerics Limited | -458 Million INR | 368.775% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 129.915% |